Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at scheduled visits 4, 5 and 6.</p
A detailed understanding of the antibody response against SARS-CoV-2 is of high importance, especial...
Serological testing is a powerful tool in epidemiological studies for understanding viral circulatio...
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified ...
Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti...
Background. Primary diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infect...
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
Background: The viral neutralization assay is the gold standard to estimate the level of immunity ag...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
2a. Baseline (pre-vaccination) anti-S and anti-N IgG in COVID-19 experienced (blue, n = 37) and COVI...
Spike-binding IgG concentration (arbitrary units [AU]/mL). Serum from NHPs included in the study wer...
Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up...
We retrospectively compared the long-term evolution of IgG anti-spike (S) and anti-nucleocapsid (N) ...
International audienceThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in De...
A detailed understanding of the antibody response against SARS-CoV-2 is of high importance, especial...
Serological testing is a powerful tool in epidemiological studies for understanding viral circulatio...
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified ...
Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti...
Background. Primary diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infect...
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
Background: The viral neutralization assay is the gold standard to estimate the level of immunity ag...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
2a. Baseline (pre-vaccination) anti-S and anti-N IgG in COVID-19 experienced (blue, n = 37) and COVI...
Spike-binding IgG concentration (arbitrary units [AU]/mL). Serum from NHPs included in the study wer...
Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up...
We retrospectively compared the long-term evolution of IgG anti-spike (S) and anti-nucleocapsid (N) ...
International audienceThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in De...
A detailed understanding of the antibody response against SARS-CoV-2 is of high importance, especial...
Serological testing is a powerful tool in epidemiological studies for understanding viral circulatio...
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late...